Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Torbay Pharmaceuticals operates a commercial-scale CDMO business specializing in terminally sterilized generic injectables for hospitals. The company supplies both licensed and unlicensed special medicinal products globally and has expanded rapidly since its acquisition by NorthEdge private equity in late 2023. It holds MHRA GMP approval and supports partners with fill/finish services for plastic and glass vials/ampoules. No proprietary clinical trial results are reported as it focuses on manufacturing rather than drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Torbay Pharmaceuticals.